Kim had just started on the new hepatitis C treatment and things seemed to be going well until he realised he was unable to get his new supply of tablets because he forgot to give his local pharmacist sufficient notice.
His script could not be filled by the time he needed it. This break, early in his treatment, could affect the outcome. In desperation, he told his viral hepatitis nurse of his predicament. The nurses organised a supply and dropped it off to him on a weekend.
The nurses say this is something they can’t do on a regular basis, but it is one example of how this team of dedicated South Australian nurses go out of their way to support the people they are caring for, to ensure the best outcomes.
Continue reading “Jewel of South Australian Viral Hepatitis Services”
The development of direct-acting antiviral (DAA) treatments has revolutionised the treatment of hepatitis C in Australia. DAAs are effective and, when patients follow the medication regime, can cure more than 90% of those who take the treatment. But at the moment there are limited resources to inform and guide health professionals as they try to provide adherence support to those undergoing DAA treatment.
Medication adherence refers to the way an individual takes a medication, including the use of the correct medication, the correct dose and time, duration and timely refilling of repeat prescriptions.
Continue reading “Helping People Adhere to Treatment Helps Treatment Succeed”